Showing items 101–200
Novel immunotherapy against several tumors including neuronal and brain tumors
Application EP-2172212-A2
European Patent Office
Compositions and methods for WT1 specific immunotherapy
Grant US-7662386-B2
United States of America
Compositions and methods for WT1 specific immunotherapy
Grant US-7655249-B2
United States of America
VACCINE THERAPY FOR CHOROIDAL NEOVASCULARIZATION
Application EP-2119447-A1
European Patent Office
Novel and powerful MHC-class II peptides derived from survivin and neurocan
Application EP-2119726-A1
European Patent Office
Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific…
Application EP-2112157-A1
European Patent Office
Tumor antigen based on products of the tumor suppressor gene WT1
Application US-7608685-B1
United States of America
Methods for the detection of cervical cancer
Grant US-7579160-B2
United States of America
Assay method for peptide specific T-cells
Grant US-7575870-B1
United States of America
Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid…
Grant US-7572882-B2
United States of America
Tumor rejection antigens
Grant US-7547439-B1
United States of America
Tumor antigen protein SART-3 and tumor antigen peptides thereof
Grant US-7541428-B2
United States of America
Tumor antigen
Grant US-7524930-B2
United States of America
Tumor antigen based on products of the tumor suppressor gene WT1
Application EP-2048160-A1
European Patent Office
Tumor antigen based on products of the tumor suppressor gene WT1
Application US-7517950-B2
United States of America
KDR peptides and vaccines comprising the same
Grant US-7514084-B2
United States of America
Human papilloma virus immunoreactive peptides
Grant US-7507538-B2
United States of America
MHC-Class II restricted melanoma antigens and their use in therapeutic methods
Grant US-7501501-B2
United States of America
TRP2 isoform TRP2-6b containing HLA-A2 restricted epitopes
Grant US-7476535-B2
United States of America
Tumor antigen
Grant US-7432354-B2
United States of America
SSX-2 peptides presented by HLA class II molecules
Grant US-7429639-B2
United States of America
Tumor antigen
Grant US-7427660-B2
United States of America
Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic…
Grant US-7419957-B2
United States of America
Tumor antigen
Grant US-7408037-B2
United States of America
Tumor antigen
Grant US-7404270-B2
United States of America
Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis…
Grant US-7399827-B1
United States of America
Tumor antigen based on products of the tumor suppressor gene WT1
Application US-7390871-B2
United States of America
Method of inducing a CTL response
Application US-7364729-B2
United States of America
ENHANCED HIV-1 VACCINES AND METHODS FOR THEIR USE
Application EP-1617865-A4
European Patent Office
MAGE-A4 antigenic peptides and uses thereof
Application US-7311914-B2
United States of America
Compositions and methods for the therapy and diagnosis of breast cancer
Grant US-7241876-B2
United States of America
Human papilloma virus immunoreactive peptides
Grant US-7189513-B2
United States of America
Epitope sequences
Application EP-1752160-A2
European Patent Office
Purification of antigen-specific T cells
Grant US-7125964-B2
United States of America
Synthetic vaccine agents
Grant US-7097837-B2
United States of America
Methods of MHC class II epitope mapping, detection of autoimmune T cells and antigens…
Grant US-7094555-B2
United States of America
Tumor antigen protein art-1 and tumor antigen peptide thereof
Grant US-7071294-B1
United States of America
Methods for diagnosis of lung cancer
Grant US-7049063-B2
United States of America
Novel compounds
Application EP-1650221-A2
European Patent Office
Tumor antigen based on products of the tumor suppressor gene WT1
Grant US-7030212-B1
United States of America
Antigenic peptides derived from telomerase
Grant US-7030211-B1
United States of America
Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid…
Grant US-7026443-B1
United States of America
Peptide-based immunotherapeutic agent
Grant US-7025964-B1
United States of America
H-Y antigen
Grant US-7008922-B2
United States of America
Methods for therapeutic vaccination
Grant US-7005498-B1
United States of America
Method of inducing a CTL response
Application US-6994851-B1
United States of America
ENHANCED HIV-1 VACCINES AND METHODS FOR THEIR USE
Application EP-1617865-A2
European Patent Office
Compositions and methods for the therapy and diagnosis of lung cancer
Grant US-6960570-B2
United States of America
CTL epitope analogs
Grant US-6951651-B2
United States of America
MHC-class II restricted melanoma antigens and their use in therapeutic methods
Grant US-6951917-B1
United States of America
MODULATORY PEPTIDE MOTIFS FOR INDUCING TH1 OR TH2 IMMUNE RESPONSE
Application WO-2004106365-A3
World Intellectual Property Organisation (WIPO)
WT1-ORIGIN HLA-DR-BINDING ANTIGEN PEPTIDE
Application WO-2005045027-A1
World Intellectual Property Organisation (WIPO)
Compositions and methods for the treatment and diagnosis of breast cancer
Grant US-6861506-B1
United States of America
CANCER ANTIGENS BASED ON TUMOR SUPPRESSOR GENE WT1 PRODUCT
Application EP-1103564-A4
European Patent Office
MODULATORY PEPTIDE MOTIFS FOR INDUCING TH1 OR TH2 IMMUNE RESPONSE
Application WO-2004106365-A2
World Intellectual Property Organisation (WIPO)
Compositions and methods for the therapy and diagnosis of breast cancer
Grant US-6828431-B1
United States of America
Tumor-associated antigen (R11)
Grant US-6809179-B1
United States of America
TUMOR ANTIGEN
Application EP-1306431-A4
European Patent Office
Compositions and methods for the therapy and diagnosis of lung cancer
Grant US-6737514-B1
United States of America
Peptide-based immunotherapeutic agent for treating allergic diseases
Grant US-6719976-B1
United States of America
Compounds and methods for therapy and diagnosis of lung cancer
Grant US-6706262-B1
United States of America
EBV CTL epitopes
Grant US-6703024-B2
United States of America
EBV CTL epitopes
Grant US-6699477-B2
United States of America
Isolated peptides which bind to HLA-B35 molecules, larger peptides which contain these…
Grant US-6667037-B1
United States of America
Compositions and methods for the treatment and diagnosis of breast cancer
Grant US-6656480-B2
United States of America
Cytotoxic T lymphocyte epitopes of the major outer membrane protein of Chlamydia…
Grant US-6653461-B2
United States of America
CTL epitope analogs
Grant US-6632435-B1
United States of America
EPITOPE SEQUENCES
Application WO-2002081646-A3
World Intellectual Property Organisation (WIPO)
TUMOR ANTIGEN
Application EP-1306431-A1
European Patent Office
Expression vectors for stimulating an immune response and methods of using the same
Grant US-6534482-B1
United States of America
Compositions and methods for the therapy and diagnosis of lung cancer
Grant US-6531315-B1
United States of America
Compounds and methods for therapy and diagnosis of lung cancer
Grant US-6518256-B1
United States of America
Compounds and methods for therapy and diagnosis of lung cancer
Grant US-6482597-B1
United States of America
EPITOPE SEQUENCES
Application WO-2002081646-A2
World Intellectual Property Organisation (WIPO)
Compositions and methods for the therapy and diagnosis of lung cancer
Grant US-6426072-B1
United States of America
COMPOSITIONS AND METHODS FOR WT1 SPECIFIC IMMUNOTHERAPY
Application WO-2001025273-A3
World Intellectual Property Organisation (WIPO)
Isolated decapeptides which bind to HLA molecules
Grant US-6384190-B1
United States of America
Method for provoking proliferation of cytolytic T cells via the use of decapeptides which…
Grant US-6368857-B1
United States of America
Isolated nona-and decapeptides which bind to HLA molecules, and the use thereof
Grant US-6326200-B1
United States of America
Isolated peptides which comply with HLA-CW16 molecules and uses
Grant US-6323028-B1
United States of America
Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof
Grant US-6277956-B1
United States of America
CANCER ANTIGENS BASED ON TUMOR SUPPRESSOR GENE WT1 PRODUCT
Application EP-1103564-A1
European Patent Office
Cytotoxic T lymphocyte epitopes of the major outer membrane protein of chlamydia…
Grant US-6225443-B1
United States of America
COMPOSITIONS AND METHODS FOR WT1 SPECIFIC IMMUNOTHERAPY
Application WO-2001025273-A2
World Intellectual Property Organisation (WIPO)
INDUCING CELLULAR IMMUNE RESPONSES TO HUMAN IMMUNODEFICIENCY VIRUS-1 USING PEPTIDE AND…
Application WO-2001024810-A1
World Intellectual Property Organisation (WIPO)
Cytotoxic T lymphocyte epitopes of the major outer membrane protein of chlamydia…
Grant US-6191259-B1
United States of America
Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen…
Grant US-6069001-A
United States of America
Chimeric MHC class I antigens for inducing allograft tolerance
Grant US-6051232-A
United States of America
VACCINATION STRATEGY TO PREVENT AND TREAT CANCERS
Application WO-1999063945-A3
World Intellectual Property Organisation (WIPO)
Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof
Grant US-6025470-A
United States of America
HLA-A2 RESTRAINT TUMOR ANTIGEN PEPTIDE ORIGINATING IN SART-1
Application WO-2000006595-A1
World Intellectual Property Organisation (WIPO)
CANCER ANTIGENS BASED ON TUMOR SUPPRESSOR GENE WT1 PRODUCT
Application WO-2000006602-A1
World Intellectual Property Organisation (WIPO)
Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof
Grant US-6019987-A
United States of America
TUMOR ANTIGEN PEPTIDE ORIGINATING IN SART-1
Application WO-2000002907-A1
World Intellectual Property Organisation (WIPO)
TUMOR ANTIGEN PEPTIDES ORIGINATING IN CYCLOPHILIN B
Application WO-1999067288-A1
World Intellectual Property Organisation (WIPO)
VACCINATION STRATEGY TO PREVENT AND TREAT CANCERS
Application WO-1999063945-A2
World Intellectual Property Organisation (WIPO)
Isolated nonapeptide which bind to HLA-B44 molecules and the uses thereof
Grant US-5977300-A
United States of America
Nucleic acid molecule encoding a bifunctional protein, the protein so encoded uses thereof
Grant US-5955313-A
United States of America
Isolated cytolytic T cells which are specific for complexes OF HLA- B35 molecules and the…
Grant US-5952228-A
United States of America
Showing items 101–200